Cancer Genetics Inc (NASDAQ:CGIX)

0.9001
Delayed Data
As of Jun 22
 -0.0899 / -9.08%
Today’s Change
0.82
Today|||52-Week Range
4.25
-51.35%
Year-to-Date
No recent news for Cancer Genetics Inc.

Today’s Trading

Previous close0.99
Today’s open0.99
Day’s range0.90 - 0.99
Volume144,229
Average volume (3 months)553,704
Market cap$25.9M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-1.00%
Earnings growth (this year)+67.33%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+7.66%
P/E ratioNM
Price/Sales1.31
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
GALTGalectin Therapeutic...-0.04-0.52%
VRMLVermillion Inc-0.10-10.65%
TRILTrillium Therapeutic...-0.05-0.75%
IDXGInterpace Diagnostic...+0.02+2.28%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$29.1M
Annual profit (last year)-$20.9M
Net profit margin-71.70%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President &
Chief Executive Officer
John A. Roberts
Vice President-
Operations
Narasimha Marella
Corporate headquarters
Rutherford, New Jersey

Forecasts